Sort   by:  
 Page size 
UnknownEnhanced clinical-scale manufacturing of TCR transduced T-cells using closed culture system modules.
Not available
S-EPMC5784598 | biostudies-literature
UnknownNon-viral chimeric antigen receptor (CAR) T cells going viral.
Not available
S-EPMC10139995 | biostudies-literature
UnknownCancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu Lung Cancer Antigen-1.
Not available
S-EPMC6712783 | biostudies-literature
UnknownHomology-independent targeted insertion (HITI) enables guided CAR knock-in and efficient clinical scale CAR-T cell manufacturing.
Not available
S-EPMC10291796 | biostudies-literature
UnknownCAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial.
Not available
S-EPMC8363505 | biostudies-literature
UnknownEffects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCL.
Not available
S-EPMC11964843 | biostudies-literature
UnknownTCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers.
Not available
S-EPMC9620481 | biostudies-literature
UnknownInosine Induces Stemness Features in CAR T cells and Enhances Potency.
Not available
S-EPMC10168291 | biostudies-literature
UnknownCD22 CAR T cells demonstrate high response rates and safety in pediatric and adult B-ALL: Phase 1b results.
Not available
S-EPMC12740236 | biostudies-literature
UnknownInosine induces stemness features in CAR-T cells and enhances potency.
Not available
S-EPMC10923096 | biostudies-literature
Sort   by:  
 Page size